4//SEC Filing
STEELE GLENN JR MD PHD 4
Accession 0001269131-26-000003
CIK 0001070081other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:20 PM ET
Size
12.8 KB
Accession
0001269131-26-000003
Insider Transaction Report
Form 4
STEELE GLENN JR MD PHD
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-02$30.86/sh+12,000$370,320→ 30,500 total - Sale
Common Stock
2026-01-02$76.35/sh−12,000$916,200→ 18,500 total - Award
Common Stock
2026-01-02+4,000→ 22,500 total - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-02−12,000→ 0 totalExercise: $30.86Exp: 2026-01-03→ Common Stock (12,000 underlying) - Award
Stock Option (Right to Buy)
2026-01-02+3,475→ 3,475 totalExercise: $76.74Exp: 2036-01-01→ Common Stock (3,475 underlying)
Footnotes (4)
- [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 8, 2025.
- [F2]Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027.
- [F3]Currently exercisable.
- [F4]This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.
Documents
Issuer
PTC THERAPEUTICS, INC.
CIK 0001070081
Entity typeother
Related Parties
1- filerCIK 0001269131
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:20 PM ET
- Size
- 12.8 KB